Corporate News     08-Mar-21
Vivimed Labs receives approval for two products from Uzbekistan Government
Vivimed Labs has received approval for 2 products from Uzbekistan Government for its PICS & Health Canada approved site, both facilities are situated at Hyderabad.

1. PRODUCT: Bilastin tablets( Brand Name FLUSTIN)- is a second-generation antihistamine (a selective histamine Hi receptor antagonist
USES: It is used in the treatment of allergic Rhino conjunctivitis and Urticaria (hives).

2. PRODUCT: Orzole combi
USES: Ofloxacin + Ornidazole is used in the treatment of bacterial & parasitic infections. It is used to treat gastrointestinal infections such as acute diarrhoea or dysentery, gynaecological infections, lung infections and urinary infections.

Previous News
  Vivimed Labs reports consolidated net loss of Rs 22.20 crore in the June 2022 quarter
 ( Results - Announcements 13-Aug-22   08:15 )
  Vivimed Labs to hold board meeting
 ( Corporate News - 29-Jun-24   17:38 )
  Vivimed Labs consolidated net profit declines 13.44% in the June 2017 quarter
 ( Results - Announcements 14-Aug-17   17:27 )
  Vivimed Labs schedules board meeting
 ( Corporate News - 31-Jan-20   11:29 )
  Vivimed Labs adjourns board meeting
 ( Corporate News - 31-May-22   11:03 )
  Next Mediaworks Ltd leads losers in 'B' group
 ( Hot Pursuit - 11-Dec-19   14:45 )
  Vivimed Labs postpones board meeting
 ( Corporate News - 18-May-24   11:32 )
  Vivimed Labs spurts after unit successfully completes USFDA inspection
 ( Hot Pursuit - 30-Nov-16   09:56 )
  Vivimed Labs intimate of successful USFDA inspection of FDF facility in Alathur
 ( Corporate News - 30-Nov-16   11:23 )
  Vivimed Labs hits roof after block deal
 ( Hot Pursuit - 27-Sep-16   14:24 )
  Vivimed Labs gains on stock-split plan
 ( Hot Pursuit - 17-Dec-15   14:20 )
Other Stories
  Share India Securities allots 16.92 lakh equity shares on conversion of warrants
  06-Jul-24   13:11
  Tinna Trade raises Rs 49 cr to fund its growth plans
  06-Jul-24   11:10
  Integra Essentia announces merger with G G Engineering
  06-Jul-24   11:05
  Ugro Capital to raise Rs 75 cr via NCD issuance
  06-Jul-24   10:58
  Board of D.P. Abhushan approves preferential allotment of shares and warrants
  06-Jul-24   10:50
  Life Insurance Corporation of India invest Rs 14 cr in Sri Lankan subsidiary
  06-Jul-24   10:49
  High Energy Batteries (India) to discuss results
  06-Jul-24   10:29
  Havells India schedules board meeting
  06-Jul-24   10:29
  Axis Bank announces board meeting date
  06-Jul-24   10:29
  Mastek to conduct board meeting
  06-Jul-24   10:29
Back Top